Meril Group to invest over Rs.910 Cr for capacity expansion in Gujarat

In a transformative stride, Meril Group has unveiled a monumental Rs. 910 crore investment at the Vibrant Gujarat Global Summit 2024. This strategic move encompasses three subsidiaries - Meril Healthcare Pvt Ltd, Micro Life Sciences Private Ltd, and Meril Life Sciences Private Limited - establishing state-of-the-art plants in Vapi.

This substantial investment aims to bolster Meril's production capacities for orthopedic implants, cardiac stents, valves, and Endo-Surgery products. The expansion project is not only set to position Meril as a market leader but also anticipates the creation of around 3,000 direct and indirect job opportunities in the region. As the Indian government identifies the medical devices sector as a sunrise industry, Meril plans to increase its capacity to develop orthopaedic implants for hip and knee as well cardiac stents & valves, alongwith Endo-Surgery products like Hernia Surgical Mesh, Linear Stapler, Hemostates, etc.

Currently, Meril is the market leader in transcatheter heart valves, bio-resorbable stents, and surgical robotic system. This strategic move not only solidifies Meril Group's standing as an industry titan but also positions Gujarat at the forefront of cutting-edge medical advancements. For a deeper insight into Meril's visionary investment and its implications on Gujarat's medical landscape, delve into the full news articles here.

https://bit.ly/3HF2I9C
https://bit.ly/3ShybDA